✦ LIBER ✦

7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086

✍ Scribed by Araujo, J.; Mathew, P.; Armstrong, A.J.; Braud, E.L.; Posadas, E.; Lonberg, M.; Gallick, G.; Trudel, G.C.; Paliwal, P.; Logothetis, C.J.

Book ID: 123475647
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 55 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71406-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of sorafenib in combinatio

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

✍ Feby Mardjuadi, Jacques Medioni, Joseph Kerger… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

7004 Final results of a randomized phase

7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)

✍ Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

710 DOSE FINDING AND EFFICACY PHASE 2 ST

710 DOSE FINDING AND EFFICACY PHASE 2 STUDY OF INECALCITOL, A NEW VDR AGONIST, IN COMBINATION WITH DOCETAXEL-PREDNISONE REGIMEN FOR CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS (PTS)

✍ Medioni, Jacques; Deplanque, Gael; Maurina, Tristan; Ferrero, Jean-Marc; Rodier, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 150 KB

4025 POSTER A phase I/II study of suniti

4025 POSTER A phase I/II study of sunitinib in combination with docetaxel (dcx) and prednisone (pdn) in patients with metastatic castrate-resistant prostate cancer (mCRPC)

✍ A. Zurita; N.D. Shore; M.F. Kozloff; C.W. Ryan; T.M. Beer; E. Chow Maneval; I. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase 1/1b study of satraplatin (JM-21

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer

✍ Cetnar, Jeremy; Wilding, George; McNeel, Douglas; LoConte, Noelle K.; McFarland, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB